Human Microbiome Market, (By Diseases - Cancer, Diabetes, Obesity, Autoimmune Disorders, Mental Disorders, Cancer and Other. By Product - Consumables, Instruments. By Technology - Cell Culture Technology, Omics Technology, Computational Tools, High-Throughput technology. By End-User - Probiotics, Prebiotics, Foods, Drugs and Diagnostic Services, Medicated Foods. By Region - North America, Europe, Asia Pacific, and LAMEA) - Global Industry Insights, Market Analysis, Trends, and Forecast 2023-2032

The global human microbiome market is projected to reach USD 1992 million by 2032 from USD 200 million in 2023, at a CAGR of 29.1% from 2023 to 2032. Human microbiome plays an important role in modern healthcare sectors. It provides several functions such as enabling digestion of food, production of various vitamins, adjustments of immune system.    

North American holds the maximum market share in human microbiome market and expected to do the same over the forecast period.

The human microbiome helps in producing vitamins such as vitamin B, vitamin K, vitamin B12, and others. Additionally, it provides essential nutrition for the human body which boosts the immunity system as well. In modern days, the human microbiome has become an essential area that is associated with several respiratory diseases. There are a few microorganisms such as firmicute, actinobacteria, and bacteroidetes that are developing lung and respiratory, diabetes, gastrointestinal problem, arthritis, and several neurological disorders. Therefore the increasing rate of these diseases and the research study of the microbiome are the main factors that are boosting the growth of the human microbiome market across the globe. Furthermore, the gut microbiome is also associated with the immunity system of a person. 

Source: SAI Research

Download Free Sample Request

The COVID-19 pandemic has driven the growth of the market over the past two years due to the rising demand for medical foods and medicines. There are several market players which have increased the R&D activities for probiotics during the pandemic period. Additionally, fecal microbiota transplantation or FMT is found to help for treatment of Clostridioides difficile infection because it works as an antibiotic and is also used to treat certain patients with COVID-19 symptoms. However, based on region, the human microbiome market is segmented into Europe, North America, Asia-Pacific, the Middle East, and Africa. The North American region is expected to witness the highest market growth through the forecast period from 2022 to 2032 owing to the growing incidence rate of gut disorders and probiotics.                    

However, among other regions, Asia-Pacific is also expected to be the fastest human microbiome market through the forecast period due to the increasing demand for microbiome-based on products and rising concern about medical foods and other medicines. Additionally, Europe is also estimated to hold the major share of the human microbiome market due to government support and the region has probiotic and prebiotic manufacturers as well. Based on application, the global human microbiome is divided into diagnostics and therapeutics. The therapeutics segment is accounted to hold the largest share in the market over the next few years.              

The key players in the global human microbiome market include DuPont, Second Genome, Series Therapeutics, Synthetic Biologics, Yakult, ENTEROME Bioscience, Seres Therapeutics, 4D Pharma, Evelo Biosciences, OptiBiotix health, Synlogic, Kaleido, BiomX, Viome Inc, Luxia Scientific, Atlas Biomed, Bione, Metabiomics, Ferring Pharmaceuticals, FlightPath, and others.             

Scope of the Report:

The Global Human Microbiome Market Has Been Segmented Into:

The Global Human Microbiome Market – by Diseases:

• Cancer
• Diabetes
• Obesity
• Autoimmune Disorders
• Mental Disorders
• Cancer
• And Other Diseases

The Global Human Microbiome Market – by Product:

• Consumables
• Instruments

The Global Human Microbiome Market – by Technology:

• Cell Culture Technology
• Omics Technology
• Computational Tools
• High-Throughput technology

The Global Human Microbiome Market – by End-User:

• Probiotics
• Prebiotics
• Foods
• Drugs and Diagnostic Services
• Medicated Foods

The Global Human Microbiome Market – by Region:

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• Italy
• U.K.
• Russia
• Rest of Europe Countries

Asia-Pacific

• India
• China
• Japan
• South Korea
• North Korea
• Rest of Asian Countries

LAMEA

• Brazil
• Saudi Arabia
• Rest of LAMEA